Your browser doesn't support javascript.
loading
Preclinical Study of a Biparatopic METxMET Antibody-Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC.
Oh, Seung Yeon; Lee, You Won; Lee, Eun Ji; Kim, Jae Hwan; Park, YoungJoon; Heo, Seong Gu; Yu, Mi Ra; Hong, Min Hee; DaSilva, John; Daly, Christopher; Cho, Byoung Chul; Lim, Sun Min; Yun, Mi Ran.
Afiliação
  • Oh SY; Department of Research Support, Yonsei Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of South Korea.
  • Lee YW; Department of Biomedical Science institute, Graduated School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of South Korea.
  • Lee EJ; Department of Research Support, Yonsei Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of South Korea.
  • Kim JH; Department of Research Support, Yonsei Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of South Korea.
  • Park Y; Department of Biomedical Science institute, Graduated School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of South Korea.
  • Heo SG; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of South Korea.
  • Yu MR; Yonsei New Il Han Institute for Integrative Lung Cancer Research, Yonsei University College of Medicine, Seoul, Republic of South Korea.
  • Hong MH; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of South Korea.
  • DaSilva J; Department of Research Support, Yonsei Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of South Korea.
  • Daly C; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of South Korea.
  • Cho BC; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
  • Lim SM; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
  • Yun MR; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of South Korea.
Clin Cancer Res ; 29(1): 221-232, 2023 01 04.
Article em En | MEDLINE | ID: mdl-36269795
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Imunoconjugados / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Imunoconjugados / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article